Jove
Visualize
Contact Us

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An overview of current and potential use of the minipig in developmental and reproductive toxicity testing.

Reproductive toxicology (Elmsford, N.Y.)·2026
Same author

FPGA-based fast bin-ratio spiking ensemble network for radioisotope identification.

Neural networks : the official journal of the International Neural Network Society·2024
Same author

"Simulect" as a model compound for assessing placental transfer of monoclonal antibodies in minipigs.

Reproductive toxicology (Elmsford, N.Y.)·2019
Same author

A shortened study design for embryo-fetal development studies in the minipig.

Reproductive toxicology (Elmsford, N.Y.)·2018
Same author

Signal management in pharmacovigilance and human risk assessment of CpG 7909, integrating embryo-fetal and post-natal developmental toxicity studies in rats and rabbits.

Reproductive toxicology (Elmsford, N.Y.)·2017
Same author

"All pigs are equal" Does the background data from juvenile Göttingen minipigs support this?

Reproductive toxicology (Elmsford, N.Y.)·2016
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 17, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Combined fertility and embryotoxicity study.

Lucie Reynaud1, Edward Marsden

  • 1Ricerca Biosciences, Saint-Germain sur l'Arbresle, France. Lucie.reynaud@ricerca.com

Methods in Molecular Biology (Clifton, N.J.)
|November 10, 2012
PubMed
Summary
This summary is machine-generated.

Combining fertility and embryo-fetal development studies, following ICH S5(R2) guidelines, reduces animal use and costs. This flexible approach streamlines reproductive toxicity testing for medicinal products.

More Related Videos

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

Determination of Reproductive Competence by Confirming Pubertal Onset and Performing a Fertility Assay in Mice and Rats
06:38

Determination of Reproductive Competence by Confirming Pubertal Onset and Performing a Fertility Assay in Mice and Rats

Published on: October 13, 2018

Related Experiment Videos

Last Updated: May 17, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

Determination of Reproductive Competence by Confirming Pubertal Onset and Performing a Fertility Assay in Mice and Rats
06:38

Determination of Reproductive Competence by Confirming Pubertal Onset and Performing a Fertility Assay in Mice and Rats

Published on: October 13, 2018

Area of Science:

  • Reproductive toxicology
  • Drug development
  • Preclinical safety assessment

Background:

  • Fertility and embryotoxicity studies are typically conducted separately per ICH S5(R2) guidelines.
  • The ICH S5(R2) guideline permits a flexible approach, allowing for combined study designs.

Purpose of the Study:

  • To evaluate the feasibility and benefits of combining fertility and embryo-fetal development studies.
  • To streamline the reproductive toxicity testing of medicinal products.

Main Methods:

  • A combined study design integrating fertility and embryo-fetal development stages (A to D) was considered.
  • Administration covers pre-mating and gestation phases up to hard palate closure.

Main Results:

  • The combined study design offers significant reductions in animal numbers.
  • Cost savings are a principal advantage of the integrated approach.

Conclusions:

  • Combining fertility and embryo-fetal development studies is a viable and efficient strategy.
  • This integrated approach aligns with the flexible nature of ICH S5(R2) guidelines for drug safety evaluation.